nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Vismodegib—Sulfasalazine—rheumatoid arthritis	0.598	1	CrCrCtD
Tolvaptan—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0307	0.115	CbGbCtD
Tolvaptan—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0249	0.0934	CbGbCtD
Tolvaptan—ABCB1—Betamethasone—rheumatoid arthritis	0.0199	0.0747	CbGbCtD
Tolvaptan—ABCB1—Prednisolone—rheumatoid arthritis	0.0197	0.0737	CbGbCtD
Tolvaptan—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0187	0.0699	CbGbCtD
Tolvaptan—ABCB1—Prednisone—rheumatoid arthritis	0.0186	0.0696	CbGbCtD
Tolvaptan—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0184	0.0689	CbGbCtD
Tolvaptan—ABCB1—Cyclosporine—rheumatoid arthritis	0.0176	0.066	CbGbCtD
Tolvaptan—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0139	0.0522	CbGbCtD
Tolvaptan—CYP3A4—Betamethasone—rheumatoid arthritis	0.012	0.0448	CbGbCtD
Tolvaptan—CYP3A4—Prednisolone—rheumatoid arthritis	0.0118	0.0442	CbGbCtD
Tolvaptan—ABCB1—Dexamethasone—rheumatoid arthritis	0.0116	0.0435	CbGbCtD
Tolvaptan—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0112	0.0419	CbGbCtD
Tolvaptan—CYP3A4—Prednisone—rheumatoid arthritis	0.0111	0.0417	CbGbCtD
Tolvaptan—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0106	0.0396	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—rheumatoid arthritis	0.00932	0.0349	CbGbCtD
Tolvaptan—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00695	0.026	CbGbCtD
Tolvaptan—Nausea—Penicillamine—rheumatoid arthritis	0.000273	0.00349	CcSEcCtD
Tolvaptan—Ill-defined disorder—Azathioprine—rheumatoid arthritis	0.000272	0.00348	CcSEcCtD
Tolvaptan—Dysgeusia—Leflunomide—rheumatoid arthritis	0.000271	0.00347	CcSEcCtD
Tolvaptan—Pulmonary embolism—Methotrexate—rheumatoid arthritis	0.00027	0.00346	CcSEcCtD
Tolvaptan—Renal failure—Cyclosporine—rheumatoid arthritis	0.000269	0.00344	CcSEcCtD
Tolvaptan—Breast disorder—Methylprednisolone—rheumatoid arthritis	0.000268	0.00343	CcSEcCtD
Tolvaptan—Malaise—Azathioprine—rheumatoid arthritis	0.000265	0.00338	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Methylprednisolone—rheumatoid arthritis	0.000262	0.00334	CcSEcCtD
Tolvaptan—Ill-defined disorder—Leflunomide—rheumatoid arthritis	0.000257	0.00329	CcSEcCtD
Tolvaptan—Malaise—Leflunomide—rheumatoid arthritis	0.00025	0.0032	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.000248	0.00317	CcSEcCtD
Tolvaptan—Discomfort—Azathioprine—rheumatoid arthritis	0.000247	0.00316	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—rheumatoid arthritis	0.000244	0.00313	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—rheumatoid arthritis	0.000244	0.00313	CcSEcCtD
Tolvaptan—Urinary tract disorder—Cyclosporine—rheumatoid arthritis	0.000243	0.0031	CcSEcCtD
Tolvaptan—Connective tissue disorder—Cyclosporine—rheumatoid arthritis	0.000241	0.00309	CcSEcCtD
Tolvaptan—Urethral disorder—Cyclosporine—rheumatoid arthritis	0.000241	0.00308	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Prednisone—rheumatoid arthritis	0.000235	0.003	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000234	0.003	CcSEcCtD
Tolvaptan—Discomfort—Leflunomide—rheumatoid arthritis	0.000233	0.00298	CcSEcCtD
Tolvaptan—Skin disorder—Azathioprine—rheumatoid arthritis	0.000233	0.00297	CcSEcCtD
Tolvaptan—Dry mouth—Leflunomide—rheumatoid arthritis	0.000231	0.00295	CcSEcCtD
Tolvaptan—Anaphylactic shock—Leflunomide—rheumatoid arthritis	0.000226	0.00289	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—rheumatoid arthritis	0.000224	0.00286	CcSEcCtD
Tolvaptan—Angiopathy—Cyclosporine—rheumatoid arthritis	0.000223	0.00285	CcSEcCtD
Tolvaptan—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000222	0.00284	CcSEcCtD
Tolvaptan—Mediastinal disorder—Cyclosporine—rheumatoid arthritis	0.000221	0.00283	CcSEcCtD
Tolvaptan—Skin disorder—Leflunomide—rheumatoid arthritis	0.00022	0.00281	CcSEcCtD
Tolvaptan—Anorexia—Leflunomide—rheumatoid arthritis	0.000216	0.00276	CcSEcCtD
Tolvaptan—Connective tissue disorder—Hydrocortisone—rheumatoid arthritis	0.000215	0.00274	CcSEcCtD
Tolvaptan—Malnutrition—Cyclosporine—rheumatoid arthritis	0.000214	0.00273	CcSEcCtD
Tolvaptan—Hyperglycaemia—Dexamethasone—rheumatoid arthritis	0.00021	0.00269	CcSEcCtD
Tolvaptan—Hyperglycaemia—Betamethasone—rheumatoid arthritis	0.00021	0.00269	CcSEcCtD
Tolvaptan—Dysgeusia—Cyclosporine—rheumatoid arthritis	0.000209	0.00268	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Prednisone—rheumatoid arthritis	0.000207	0.00265	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000207	0.00264	CcSEcCtD
Tolvaptan—Connective tissue disorder—Methylprednisolone—rheumatoid arthritis	0.000202	0.00258	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—rheumatoid arthritis	0.0002	0.00256	CcSEcCtD
Tolvaptan—Ill-defined disorder—Cyclosporine—rheumatoid arthritis	0.000198	0.00254	CcSEcCtD
Tolvaptan—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.000197	0.00252	CcSEcCtD
Tolvaptan—Immune system disorder—Hydrocortisone—rheumatoid arthritis	0.000197	0.00252	CcSEcCtD
Tolvaptan—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000197	0.00251	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000195	0.0025	CcSEcCtD
Tolvaptan—Constipation—Leflunomide—rheumatoid arthritis	0.000193	0.00247	CcSEcCtD
Tolvaptan—Malaise—Cyclosporine—rheumatoid arthritis	0.000193	0.00247	CcSEcCtD
Tolvaptan—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.00019	0.00243	CcSEcCtD
Tolvaptan—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.00019	0.00243	CcSEcCtD
Tolvaptan—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000189	0.00242	CcSEcCtD
Tolvaptan—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.000186	0.00238	CcSEcCtD
Tolvaptan—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000186	0.00238	CcSEcCtD
Tolvaptan—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.000185	0.00237	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000185	0.00236	CcSEcCtD
Tolvaptan—Hyperglycaemia—Prednisone—rheumatoid arthritis	0.000183	0.00234	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000181	0.00231	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisolone—rheumatoid arthritis	0.000181	0.00231	CcSEcCtD
Tolvaptan—Discomfort—Cyclosporine—rheumatoid arthritis	0.00018	0.0023	CcSEcCtD
Tolvaptan—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000179	0.00229	CcSEcCtD
Tolvaptan—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000179	0.00228	CcSEcCtD
Tolvaptan—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000178	0.00228	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—rheumatoid arthritis	0.000177	0.00227	CcSEcCtD
Tolvaptan—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000176	0.00226	CcSEcCtD
Tolvaptan—Ill-defined disorder—Hydrocortisone—rheumatoid arthritis	0.000176	0.00225	CcSEcCtD
Tolvaptan—Malaise—Prednisolone—rheumatoid arthritis	0.000176	0.00224	CcSEcCtD
Tolvaptan—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.000175	0.00224	CcSEcCtD
Tolvaptan—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000175	0.00223	CcSEcCtD
Tolvaptan—Syncope—Prednisolone—rheumatoid arthritis	0.000175	0.00223	CcSEcCtD
Tolvaptan—Malaise—Hydrocortisone—rheumatoid arthritis	0.000171	0.00219	CcSEcCtD
Tolvaptan—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000171	0.00219	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000171	0.00219	CcSEcCtD
Tolvaptan—Syncope—Hydrocortisone—rheumatoid arthritis	0.00017	0.00218	CcSEcCtD
Tolvaptan—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00017	0.00217	CcSEcCtD
Tolvaptan—Angiopathy—Betamethasone—rheumatoid arthritis	0.000169	0.00216	CcSEcCtD
Tolvaptan—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000169	0.00216	CcSEcCtD
Tolvaptan—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.000167	0.00214	CcSEcCtD
Tolvaptan—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000167	0.00213	CcSEcCtD
Tolvaptan—Anorexia—Cyclosporine—rheumatoid arthritis	0.000166	0.00213	CcSEcCtD
Tolvaptan—Ill-defined disorder—Triamcinolone—rheumatoid arthritis	0.000166	0.00212	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methylprednisolone—rheumatoid arthritis	0.000166	0.00212	CcSEcCtD
Tolvaptan—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000164	0.0021	CcSEcCtD
Tolvaptan—Discomfort—Prednisolone—rheumatoid arthritis	0.000164	0.00209	CcSEcCtD
Tolvaptan—Asthenia—Leflunomide—rheumatoid arthritis	0.000162	0.00207	CcSEcCtD
Tolvaptan—Malaise—Triamcinolone—rheumatoid arthritis	0.000161	0.00206	CcSEcCtD
Tolvaptan—Malaise—Methylprednisolone—rheumatoid arthritis	0.000161	0.00206	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000161	0.00205	CcSEcCtD
Tolvaptan—Syncope—Triamcinolone—rheumatoid arthritis	0.000161	0.00205	CcSEcCtD
Tolvaptan—Syncope—Methylprednisolone—rheumatoid arthritis	0.00016	0.00205	CcSEcCtD
Tolvaptan—Pruritus—Leflunomide—rheumatoid arthritis	0.00016	0.00205	CcSEcCtD
Tolvaptan—Discomfort—Hydrocortisone—rheumatoid arthritis	0.00016	0.00204	CcSEcCtD
Tolvaptan—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.00016	0.00204	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.000159	0.00203	CcSEcCtD
Tolvaptan—Dizziness—Azathioprine—rheumatoid arthritis	0.000158	0.00202	CcSEcCtD
Tolvaptan—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000157	0.00201	CcSEcCtD
Tolvaptan—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000157	0.00201	CcSEcCtD
Tolvaptan—Shock—Prednisolone—rheumatoid arthritis	0.000156	0.002	CcSEcCtD
Tolvaptan—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000155	0.00198	CcSEcCtD
Tolvaptan—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000155	0.00198	CcSEcCtD
Tolvaptan—Shock—Hydrocortisone—rheumatoid arthritis	0.000153	0.00195	CcSEcCtD
Tolvaptan—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000152	0.00195	CcSEcCtD
Tolvaptan—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000152	0.00194	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000151	0.00193	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000151	0.00193	CcSEcCtD
Tolvaptan—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000151	0.00193	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	0.000151	0.00193	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betamethasone—rheumatoid arthritis	0.000151	0.00193	CcSEcCtD
Tolvaptan—Discomfort—Triamcinolone—rheumatoid arthritis	0.000151	0.00192	CcSEcCtD
Tolvaptan—Discomfort—Methylprednisolone—rheumatoid arthritis	0.00015	0.00192	CcSEcCtD
Tolvaptan—Headache—Azathioprine—rheumatoid arthritis	0.00015	0.00192	CcSEcCtD
Tolvaptan—Dizziness—Leflunomide—rheumatoid arthritis	0.00015	0.00191	CcSEcCtD
Tolvaptan—Constipation—Cyclosporine—rheumatoid arthritis	0.000149	0.00191	CcSEcCtD
Tolvaptan—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000149	0.00191	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—rheumatoid arthritis	0.000149	0.0019	CcSEcCtD
Tolvaptan—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000148	0.00189	CcSEcCtD
Tolvaptan—Angiopathy—Prednisone—rheumatoid arthritis	0.000147	0.00188	CcSEcCtD
Tolvaptan—Immune system disorder—Prednisone—rheumatoid arthritis	0.000147	0.00188	CcSEcCtD
Tolvaptan—Malaise—Dexamethasone—rheumatoid arthritis	0.000146	0.00187	CcSEcCtD
Tolvaptan—Malaise—Betamethasone—rheumatoid arthritis	0.000146	0.00187	CcSEcCtD
Tolvaptan—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000146	0.00187	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000146	0.00186	CcSEcCtD
Tolvaptan—Syncope—Dexamethasone—rheumatoid arthritis	0.000146	0.00186	CcSEcCtD
Tolvaptan—Syncope—Betamethasone—rheumatoid arthritis	0.000146	0.00186	CcSEcCtD
Tolvaptan—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000144	0.00184	CcSEcCtD
Tolvaptan—Shock—Triamcinolone—rheumatoid arthritis	0.000144	0.00184	CcSEcCtD
Tolvaptan—Shock—Methylprednisolone—rheumatoid arthritis	0.000143	0.00183	CcSEcCtD
Tolvaptan—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000143	0.00183	CcSEcCtD
Tolvaptan—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000143	0.00182	CcSEcCtD
Tolvaptan—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000143	0.00182	CcSEcCtD
Tolvaptan—Nausea—Azathioprine—rheumatoid arthritis	0.000142	0.00182	CcSEcCtD
Tolvaptan—Headache—Leflunomide—rheumatoid arthritis	0.000142	0.00181	CcSEcCtD
Tolvaptan—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000142	0.00181	CcSEcCtD
Tolvaptan—Malnutrition—Prednisone—rheumatoid arthritis	0.000141	0.00181	CcSEcCtD
Tolvaptan—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000138	0.00176	CcSEcCtD
Tolvaptan—Discomfort—Dexamethasone—rheumatoid arthritis	0.000137	0.00175	CcSEcCtD
Tolvaptan—Discomfort—Betamethasone—rheumatoid arthritis	0.000137	0.00175	CcSEcCtD
Tolvaptan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000135	0.00172	CcSEcCtD
Tolvaptan—Nausea—Leflunomide—rheumatoid arthritis	0.000134	0.00172	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000134	0.00171	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000134	0.00171	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000133	0.0017	CcSEcCtD
Tolvaptan—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000133	0.00169	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000133	0.00169	CcSEcCtD
Tolvaptan—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000131	0.00168	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000131	0.00167	CcSEcCtD
Tolvaptan—Shock—Betamethasone—rheumatoid arthritis	0.00013	0.00167	CcSEcCtD
Tolvaptan—Shock—Dexamethasone—rheumatoid arthritis	0.00013	0.00167	CcSEcCtD
Tolvaptan—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00013	0.00166	CcSEcCtD
Tolvaptan—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00013	0.00166	CcSEcCtD
Tolvaptan—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000129	0.00164	CcSEcCtD
Tolvaptan—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000128	0.00163	CcSEcCtD
Tolvaptan—Malaise—Prednisone—rheumatoid arthritis	0.000128	0.00163	CcSEcCtD
Tolvaptan—Syncope—Prednisone—rheumatoid arthritis	0.000127	0.00162	CcSEcCtD
Tolvaptan—Anorexia—Betamethasone—rheumatoid arthritis	0.000126	0.00162	CcSEcCtD
Tolvaptan—Anorexia—Dexamethasone—rheumatoid arthritis	0.000126	0.00162	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000126	0.00161	CcSEcCtD
Tolvaptan—Asthenia—Cyclosporine—rheumatoid arthritis	0.000125	0.0016	CcSEcCtD
Tolvaptan—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000124	0.00159	CcSEcCtD
Tolvaptan—Pruritus—Cyclosporine—rheumatoid arthritis	0.000123	0.00158	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—rheumatoid arthritis	0.000123	0.00158	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000123	0.00157	CcSEcCtD
Tolvaptan—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000123	0.00157	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000122	0.00156	CcSEcCtD
Tolvaptan—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.00012	0.00154	CcSEcCtD
Tolvaptan—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00012	0.00154	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00012	0.00153	CcSEcCtD
Tolvaptan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000119	0.00153	CcSEcCtD
Tolvaptan—Discomfort—Prednisone—rheumatoid arthritis	0.000119	0.00152	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—rheumatoid arthritis	0.000118	0.00151	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000117	0.0015	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000116	0.00148	CcSEcCtD
Tolvaptan—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000115	0.00148	CcSEcCtD
Tolvaptan—Dizziness—Cyclosporine—rheumatoid arthritis	0.000115	0.00148	CcSEcCtD
Tolvaptan—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000115	0.00148	CcSEcCtD
Tolvaptan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000115	0.00147	CcSEcCtD
Tolvaptan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000115	0.00147	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000114	0.00146	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000114	0.00146	CcSEcCtD
Tolvaptan—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000114	0.00146	CcSEcCtD
Tolvaptan—Shock—Prednisone—rheumatoid arthritis	0.000114	0.00145	CcSEcCtD
Tolvaptan—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000113	0.00145	CcSEcCtD
Tolvaptan—Skin disorder—Prednisone—rheumatoid arthritis	0.000112	0.00143	CcSEcCtD
Tolvaptan—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000111	0.00142	CcSEcCtD
Tolvaptan—Anorexia—Prednisone—rheumatoid arthritis	0.00011	0.00141	CcSEcCtD
Tolvaptan—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00011	0.0014	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.00011	0.0014	CcSEcCtD
Tolvaptan—Headache—Cyclosporine—rheumatoid arthritis	0.000109	0.0014	CcSEcCtD
Tolvaptan—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000109	0.0014	CcSEcCtD
Tolvaptan—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000109	0.0014	CcSEcCtD
Tolvaptan—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000108	0.00138	CcSEcCtD
Tolvaptan—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000107	0.00137	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—rheumatoid arthritis	0.000107	0.00136	CcSEcCtD
Tolvaptan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000106	0.00136	CcSEcCtD
Tolvaptan—Dizziness—Prednisolone—rheumatoid arthritis	0.000105	0.00134	CcSEcCtD
Tolvaptan—Asthenia—Triamcinolone—rheumatoid arthritis	0.000105	0.00134	CcSEcCtD
Tolvaptan—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000105	0.00134	CcSEcCtD
Tolvaptan—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000105	0.00134	CcSEcCtD
Tolvaptan—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000105	0.00134	CcSEcCtD
Tolvaptan—Nausea—Cyclosporine—rheumatoid arthritis	0.000104	0.00133	CcSEcCtD
Tolvaptan—Pruritus—Triamcinolone—rheumatoid arthritis	0.000103	0.00132	CcSEcCtD
Tolvaptan—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000103	0.00132	CcSEcCtD
Tolvaptan—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000103	0.00131	CcSEcCtD
Tolvaptan—Decreased appetite—Prednisone—rheumatoid arthritis	0.0001	0.00128	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.99e-05	0.00128	CcSEcCtD
Tolvaptan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.97e-05	0.00128	CcSEcCtD
Tolvaptan—Headache—Prednisolone—rheumatoid arthritis	9.95e-05	0.00127	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—rheumatoid arthritis	9.94e-05	0.00127	CcSEcCtD
Tolvaptan—Constipation—Prednisone—rheumatoid arthritis	9.87e-05	0.00126	CcSEcCtD
Tolvaptan—Headache—Hydrocortisone—rheumatoid arthritis	9.72e-05	0.00124	CcSEcCtD
Tolvaptan—Dizziness—Triamcinolone—rheumatoid arthritis	9.66e-05	0.00124	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—rheumatoid arthritis	9.65e-05	0.00123	CcSEcCtD
Tolvaptan—Dizziness—Methylprednisolone—rheumatoid arthritis	9.64e-05	0.00123	CcSEcCtD
Tolvaptan—Feeling abnormal—Prednisone—rheumatoid arthritis	9.51e-05	0.00122	CcSEcCtD
Tolvaptan—Asthenia—Betamethasone—rheumatoid arthritis	9.51e-05	0.00122	CcSEcCtD
Tolvaptan—Asthenia—Dexamethasone—rheumatoid arthritis	9.51e-05	0.00122	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—rheumatoid arthritis	9.46e-05	0.00121	CcSEcCtD
Tolvaptan—Nausea—Prednisolone—rheumatoid arthritis	9.43e-05	0.00121	CcSEcCtD
Tolvaptan—Pruritus—Betamethasone—rheumatoid arthritis	9.38e-05	0.0012	CcSEcCtD
Tolvaptan—Pruritus—Dexamethasone—rheumatoid arthritis	9.38e-05	0.0012	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—rheumatoid arthritis	9.37e-05	0.0012	CcSEcCtD
Tolvaptan—Nausea—Hydrocortisone—rheumatoid arthritis	9.21e-05	0.00118	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—rheumatoid arthritis	9.2e-05	0.00118	CcSEcCtD
Tolvaptan—Headache—Triamcinolone—rheumatoid arthritis	9.15e-05	0.00117	CcSEcCtD
Tolvaptan—Headache—Methylprednisolone—rheumatoid arthritis	9.13e-05	0.00117	CcSEcCtD
Tolvaptan—Body temperature increased—Prednisone—rheumatoid arthritis	9.12e-05	0.00117	CcSEcCtD
Tolvaptan—Diarrhoea—Dexamethasone—rheumatoid arthritis	9.07e-05	0.00116	CcSEcCtD
Tolvaptan—Diarrhoea—Betamethasone—rheumatoid arthritis	9.07e-05	0.00116	CcSEcCtD
Tolvaptan—Dizziness—Dexamethasone—rheumatoid arthritis	8.76e-05	0.00112	CcSEcCtD
Tolvaptan—Dizziness—Betamethasone—rheumatoid arthritis	8.76e-05	0.00112	CcSEcCtD
Tolvaptan—Nausea—Triamcinolone—rheumatoid arthritis	8.68e-05	0.00111	CcSEcCtD
Tolvaptan—Nausea—Methylprednisolone—rheumatoid arthritis	8.66e-05	0.00111	CcSEcCtD
Tolvaptan—Hypersensitivity—Prednisone—rheumatoid arthritis	8.5e-05	0.00109	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—rheumatoid arthritis	8.39e-05	0.00107	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	8.33e-05	0.00106	CcSEcCtD
Tolvaptan—Headache—Betamethasone—rheumatoid arthritis	8.3e-05	0.00106	CcSEcCtD
Tolvaptan—Headache—Dexamethasone—rheumatoid arthritis	8.3e-05	0.00106	CcSEcCtD
Tolvaptan—Asthenia—Prednisone—rheumatoid arthritis	8.28e-05	0.00106	CcSEcCtD
Tolvaptan—Pruritus—Prednisone—rheumatoid arthritis	8.17e-05	0.00104	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—rheumatoid arthritis	7.95e-05	0.00102	CcSEcCtD
Tolvaptan—Diarrhoea—Prednisone—rheumatoid arthritis	7.9e-05	0.00101	CcSEcCtD
Tolvaptan—Nausea—Dexamethasone—rheumatoid arthritis	7.87e-05	0.00101	CcSEcCtD
Tolvaptan—Nausea—Betamethasone—rheumatoid arthritis	7.87e-05	0.00101	CcSEcCtD
Tolvaptan—Dizziness—Prednisone—rheumatoid arthritis	7.63e-05	0.000976	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—rheumatoid arthritis	7.63e-05	0.000975	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	7.27e-05	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-B—rheumatoid arthritis	7.25e-05	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—LEP—rheumatoid arthritis	7.24e-05	0.00127	CbGpPWpGaD
Tolvaptan—Headache—Prednisone—rheumatoid arthritis	7.23e-05	0.000925	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—POMC—rheumatoid arthritis	7.21e-05	0.00126	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—POMC—rheumatoid arthritis	7.16e-05	0.00125	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Methotrexate—rheumatoid arthritis	7.11e-05	0.000909	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	7.1e-05	0.00124	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FASLG—rheumatoid arthritis	7.09e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CCL2—rheumatoid arthritis	7.06e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	7.05e-05	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CCL2—rheumatoid arthritis	7.01e-05	0.00123	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	6.94e-05	0.00122	CbGpPWpGaD
Tolvaptan—Asthenia—Methotrexate—rheumatoid arthritis	6.92e-05	0.000885	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL12—rheumatoid arthritis	6.91e-05	0.00121	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	6.91e-05	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	6.89e-05	0.00121	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL12—rheumatoid arthritis	6.86e-05	0.0012	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—BDKRB2—rheumatoid arthritis	6.86e-05	0.0012	CbGpPWpGaD
Tolvaptan—Nausea—Prednisone—rheumatoid arthritis	6.86e-05	0.000877	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—FAS—rheumatoid arthritis	6.84e-05	0.0012	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	6.83e-05	0.0012	CbGpPWpGaD
Tolvaptan—Pruritus—Methotrexate—rheumatoid arthritis	6.82e-05	0.000873	CcSEcCtD
Tolvaptan—ABCB1—Allograft Rejection—IL2RA—rheumatoid arthritis	6.8e-05	0.00119	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—ADRBK1—rheumatoid arthritis	6.78e-05	0.00119	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—NOS2—rheumatoid arthritis	6.75e-05	0.00118	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—C3—rheumatoid arthritis	6.74e-05	0.00118	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL13—rheumatoid arthritis	6.74e-05	0.00118	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL10—rheumatoid arthritis	6.73e-05	0.00118	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-A—rheumatoid arthritis	6.72e-05	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL13—rheumatoid arthritis	6.69e-05	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL10—rheumatoid arthritis	6.68e-05	0.00117	CbGpPWpGaD
Tolvaptan—Diarrhoea—Methotrexate—rheumatoid arthritis	6.6e-05	0.000844	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	6.44e-05	0.00113	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RASGRP1—rheumatoid arthritis	6.4e-05	0.00112	CbGpPWpGaD
Tolvaptan—Dizziness—Methotrexate—rheumatoid arthritis	6.38e-05	0.000816	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	6.31e-05	0.0011	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCQ—rheumatoid arthritis	6.26e-05	0.0011	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	6.19e-05	0.00108	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	6.14e-05	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL10—rheumatoid arthritis	6.11e-05	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRAK1—rheumatoid arthritis	6.07e-05	0.00106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TLE3—rheumatoid arthritis	6.07e-05	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL10—rheumatoid arthritis	6.06e-05	0.00106	CbGpPWpGaD
Tolvaptan—Headache—Methotrexate—rheumatoid arthritis	6.04e-05	0.000773	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—IRAK1—rheumatoid arthritis	6.02e-05	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TLE3—rheumatoid arthritis	6.02e-05	0.00105	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CX3CR1—rheumatoid arthritis	6.01e-05	0.00105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CX3CR1—rheumatoid arthritis	5.96e-05	0.00104	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCL5—rheumatoid arthritis	5.79e-05	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2RB—rheumatoid arthritis	5.78e-05	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCL5—rheumatoid arthritis	5.75e-05	0.00101	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2RB—rheumatoid arthritis	5.74e-05	0.001	CbGpPWpGaD
Tolvaptan—Nausea—Methotrexate—rheumatoid arthritis	5.73e-05	0.000733	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—CSF2—rheumatoid arthritis	5.7e-05	0.000998	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CD80—rheumatoid arthritis	5.67e-05	0.000993	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CSF2—rheumatoid arthritis	5.66e-05	0.000991	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—C5—rheumatoid arthritis	5.58e-05	0.000978	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—CXCL8—rheumatoid arthritis	5.58e-05	0.000977	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MMP3—rheumatoid arthritis	5.57e-05	0.000975	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	5.56e-05	0.000973	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—C5—rheumatoid arthritis	5.54e-05	0.00097	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—CXCL8—rheumatoid arthritis	5.54e-05	0.00097	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MMP3—rheumatoid arthritis	5.53e-05	0.000968	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFATC1—rheumatoid arthritis	5.49e-05	0.000962	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFATC1—rheumatoid arthritis	5.45e-05	0.000955	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL5—rheumatoid arthritis	5.26e-05	0.00092	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR6—rheumatoid arthritis	5.25e-05	0.000919	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL5—rheumatoid arthritis	5.22e-05	0.000914	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CCR5—rheumatoid arthritis	5.22e-05	0.000913	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR6—rheumatoid arthritis	5.21e-05	0.000912	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CSF2—rheumatoid arthritis	5.18e-05	0.000907	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CCR5—rheumatoid arthritis	5.18e-05	0.000907	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CSF2—rheumatoid arthritis	5.14e-05	0.0009	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2RA—rheumatoid arthritis	5.14e-05	0.0009	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCF2—rheumatoid arthritis	5.11e-05	0.000894	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	5.1e-05	0.000894	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—C3—rheumatoid arthritis	5.1e-05	0.000892	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCF2—rheumatoid arthritis	5.07e-05	0.000888	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—C3—rheumatoid arthritis	5.06e-05	0.000886	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.05e-05	0.000885	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SH2B3—rheumatoid arthritis	4.98e-05	0.000871	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TRAF6—rheumatoid arthritis	4.98e-05	0.000871	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GZMB—rheumatoid arthritis	4.95e-05	0.000866	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SH2B3—rheumatoid arthritis	4.94e-05	0.000865	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TRAF6—rheumatoid arthritis	4.94e-05	0.000865	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GZMB—rheumatoid arthritis	4.91e-05	0.00086	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	4.91e-05	0.00086	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL2—rheumatoid arthritis	4.8e-05	0.000841	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL3—rheumatoid arthritis	4.8e-05	0.000841	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL3—rheumatoid arthritis	4.77e-05	0.000835	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL2—rheumatoid arthritis	4.77e-05	0.000835	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCR5—rheumatoid arthritis	4.74e-05	0.000829	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCR5—rheumatoid arthritis	4.7e-05	0.000823	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SAA1—rheumatoid arthritis	4.7e-05	0.000822	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.67e-05	0.000817	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SAA1—rheumatoid arthritis	4.66e-05	0.000816	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.63e-05	0.000811	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—C3—rheumatoid arthritis	4.63e-05	0.00081	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCF1—rheumatoid arthritis	4.6e-05	0.000805	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—C3—rheumatoid arthritis	4.6e-05	0.000805	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCF1—rheumatoid arthritis	4.56e-05	0.000799	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IFNG—rheumatoid arthritis	4.48e-05	0.000785	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	4.45e-05	0.000779	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD28—rheumatoid arthritis	4.42e-05	0.000774	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD28—rheumatoid arthritis	4.39e-05	0.000769	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	4.29e-05	0.000752	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—rheumatoid arthritis	4.17e-05	0.00073	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.16e-05	0.000729	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	4.14e-05	0.000724	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.13e-05	0.000724	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL12—rheumatoid arthritis	4.08e-05	0.000715	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.08e-05	0.000715	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—rheumatoid arthritis	4.08e-05	0.000714	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.05e-05	0.00071	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL12—rheumatoid arthritis	4.05e-05	0.00071	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.05e-05	0.000709	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—rheumatoid arthritis	4.05e-05	0.000709	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.04e-05	0.000707	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.02e-05	0.000704	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.01e-05	0.000702	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—rheumatoid arthritis	4e-05	0.0007	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—rheumatoid arthritis	3.98e-05	0.000698	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	3.91e-05	0.000685	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.81e-05	0.000667	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SYK—rheumatoid arthritis	3.8e-05	0.000664	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.78e-05	0.000662	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SYK—rheumatoid arthritis	3.77e-05	0.00066	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.73e-05	0.000652	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—rheumatoid arthritis	3.7e-05	0.000648	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.7e-05	0.000648	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—rheumatoid arthritis	3.68e-05	0.000643	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT1—rheumatoid arthritis	3.66e-05	0.000641	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT1—rheumatoid arthritis	3.63e-05	0.000636	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—rheumatoid arthritis	3.62e-05	0.000634	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6R—rheumatoid arthritis	3.61e-05	0.000632	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL10—rheumatoid arthritis	3.61e-05	0.000632	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—rheumatoid arthritis	3.6e-05	0.00063	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6R—rheumatoid arthritis	3.58e-05	0.000628	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL10—rheumatoid arthritis	3.58e-05	0.000627	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	3.5e-05	0.000613	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	3.5e-05	0.000612	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FADS2—rheumatoid arthritis	3.41e-05	0.000597	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—rheumatoid arthritis	3.39e-05	0.000593	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	3.37e-05	0.000591	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	3.35e-05	0.000587	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP3—rheumatoid arthritis	3.29e-05	0.000576	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.29e-05	0.000576	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP3—rheumatoid arthritis	3.27e-05	0.000572	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.27e-05	0.000572	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTK2—rheumatoid arthritis	3.17e-05	0.000555	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.15e-05	0.000552	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTK2—rheumatoid arthritis	3.14e-05	0.000551	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.13e-05	0.000548	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TGFB1—rheumatoid arthritis	3.11e-05	0.000544	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL5—rheumatoid arthritis	3.11e-05	0.000544	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL5—rheumatoid arthritis	3.08e-05	0.00054	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CSF2—rheumatoid arthritis	3.06e-05	0.000536	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CSF2—rheumatoid arthritis	3.04e-05	0.000532	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.01e-05	0.000528	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—rheumatoid arthritis	2.99e-05	0.000524	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—rheumatoid arthritis	2.9e-05	0.000508	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SPP1—rheumatoid arthritis	2.88e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.86e-05	0.000501	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SPP1—rheumatoid arthritis	2.86e-05	0.0005	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.84e-05	0.000498	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—rheumatoid arthritis	2.8e-05	0.00049	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—rheumatoid arthritis	2.78e-05	0.000486	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2RA—rheumatoid arthritis	2.76e-05	0.000483	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.74e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—rheumatoid arthritis	2.74e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—C3—rheumatoid arthritis	2.73e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—rheumatoid arthritis	2.72e-05	0.000476	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—C3—rheumatoid arthritis	2.71e-05	0.000475	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	2.67e-05	0.000468	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—rheumatoid arthritis	2.55e-05	0.000446	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—rheumatoid arthritis	2.53e-05	0.000442	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FN1—rheumatoid arthritis	2.4e-05	0.00042	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.39e-05	0.000419	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FN1—rheumatoid arthritis	2.38e-05	0.000417	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.37e-05	0.000416	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CD80—rheumatoid arthritis	2.3e-05	0.000403	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CD80—rheumatoid arthritis	2.28e-05	0.0004	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLD4—rheumatoid arthritis	2.28e-05	0.000399	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACAN—rheumatoid arthritis	2.2e-05	0.000385	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—rheumatoid arthritis	2.19e-05	0.000383	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—rheumatoid arthritis	2.17e-05	0.00038	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—rheumatoid arthritis	2.14e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6R—rheumatoid arthritis	2.13e-05	0.000373	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—rheumatoid arthritis	2.12e-05	0.000372	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	2.12e-05	0.000371	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6R—rheumatoid arthritis	2.12e-05	0.000371	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	2.1e-05	0.000368	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	2.07e-05	0.000362	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GC—rheumatoid arthritis	2.01e-05	0.000352	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGES—rheumatoid arthritis	2.01e-05	0.000352	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TYK2—rheumatoid arthritis	1.94e-05	0.00034	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TYK2—rheumatoid arthritis	1.93e-05	0.000338	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.91e-05	0.000334	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—rheumatoid arthritis	1.89e-05	0.000331	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.87e-05	0.000327	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.84e-05	0.000322	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.81e-05	0.000317	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	1.78e-05	0.000312	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.69e-05	0.000296	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.68e-05	0.000294	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.67e-05	0.000293	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MED1—rheumatoid arthritis	1.64e-05	0.000287	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—rheumatoid arthritis	1.62e-05	0.000283	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.61e-05	0.000282	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—rheumatoid arthritis	1.6e-05	0.000281	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—rheumatoid arthritis	1.6e-05	0.00028	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.53e-05	0.000269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.53e-05	0.000268	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	1.52e-05	0.000267	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACP5—rheumatoid arthritis	1.52e-05	0.000267	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—rheumatoid arthritis	1.52e-05	0.000266	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.51e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.5e-05	0.000263	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.49e-05	0.000261	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.48e-05	0.000259	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.43e-05	0.000251	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.4e-05	0.000246	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.37e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BGN—rheumatoid arthritis	1.37e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.36e-05	0.000239	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.35e-05	0.000237	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.27e-05	0.000223	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	1.26e-05	0.000221	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.26e-05	0.000221	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.26e-05	0.000221	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.25e-05	0.000219	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.24e-05	0.000217	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.24e-05	0.000217	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.15e-05	0.000202	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—rheumatoid arthritis	1.04e-05	0.000182	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—rheumatoid arthritis	1.03e-05	0.00018	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO1—rheumatoid arthritis	1.03e-05	0.00018	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.01e-05	0.000177	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	9.63e-06	0.000169	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—rheumatoid arthritis	9.5e-06	0.000166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—rheumatoid arthritis	9.43e-06	0.000165	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	9.39e-06	0.000164	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	9.39e-06	0.000164	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BGN—rheumatoid arthritis	8.45e-06	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	7.78e-06	0.000136	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—rheumatoid arthritis	7.41e-06	0.00013	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	6.34e-06	0.000111	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	6.18e-06	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—rheumatoid arthritis	4.95e-06	8.66e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—rheumatoid arthritis	4.57e-06	7.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—rheumatoid arthritis	4.51e-06	7.89e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—rheumatoid arthritis	4.31e-06	7.55e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.94e-06	6.91e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	3.81e-06	6.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—rheumatoid arthritis	3.05e-06	5.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.78e-06	4.86e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.66e-06	4.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	2.43e-06	4.26e-05	CbGpPWpGaD
